The U.S. has launched a trade investigation into a German plan to cut spending on pharmaceuticals, a move that could result in fresh tariffsWSJ • 06/19/26
FDA accepts supplemental Biologics License Application for Roche's Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphomaGlobeNewsWire • 06/18/26
FDA Accepts Supplemental Biologics License Application for Genentech's Lunsumio and Polivy Combination for People With Relapsed or Refractory Large B-Cell LymphomaBusiness Wire • 06/18/26
Roche's Tecentriq Plus Chemo Gets FDA Priority Tag for Colon CancerZacks Investment Research • 06/11/26
FDA Grants Priority Review for Genentech's Tecentriq for a Certain Type of Stage III Colon CancerBusiness Wire • 06/11/26
Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapiesPRNewsWire • 06/11/26
FDA grants Priority Review for Roche's Tecentriq for a certain type of stage III colon cancerGlobeNewsWire • 06/11/26
Roche Vs. Pfizer: Obesity Week Presentations Deep Dive - What Investors Must KnowSeeking Alpha • 06/10/26
Roche Inks $2.3 Billion Deal, Sending This Small Biotech Stock FlyingInvestors Business Daily • 06/08/26
Nurix Therapeutics Gains Ground As Roche Partnership Targets Growing B-Cell Blood Cancer MarketBenzinga • 06/08/26